MediSieve is a medical device company developing and commercializing a therapeutic platform for the treatment of blood-borne diseases. Its technology can selectively remove harmful substances from the bloodstream by continuously circulating a patient’s blood through the system similarly to dialysis. The company's targets include sepsis, malaria, and leukaemia.